Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FC Patch Low versus EVRA transdermal contraceptive patch trial
NL-OMON33166Phase 3Active, not recruiting
- Sponsor
- Bayer
- Start
- May 2009
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of ethinyl estradiol + norelgestromin in contraception, sponsored by Bayer. Started May 2009; status: active, not recruiting.
02
Drugs
ethinyl estradiol + norelgestromin
03
Conditions
contraception
Beyond the preview
Go deeper on NL-OMON33166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33166.